The association between glycaemic variability and sleep quality and quantity in adults with type 1 and type 2 diabetes: a systematic review
Pham CT, Ali A, Churilov L, et al.
Diabet Med. 2024:e15485.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and/or obesity: a systematic review and network meta-analysis
Bao Y, Hu Y, Shi M, Zhao Z
Diabetes Obes Metab. Pub. online 6 Dec 2024.
Leggi
Glucocorticoid treatment and new-onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: a systematic review and meta-analysis
Golubic R, Mumbole H, Ismail MH, et al.
Diabet Med. 2024:e15475.
Leggi
An exploratory analysis of glucagon-like peptide-1 (GLP-1) agonists and biosimilars: a literature review
Wen J, Razick A, How-Volkman C, et al.
Diabetes Obes Metab. Pub. online 9 Dec 2024.
Leggi
The effect of vitamin D3 supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial
Virtanen JK, Hantunen S, Kallio N, et al.
Diabetologia. Pub. online 2 Dec 2024.
Leggi
Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes
Hua Z, Yang S, Li J, et al.
Diabetes Obes Metab. Pub. online 1 Dec 2024.
Leggi
Replacing dietary carbohydrate with protein and fat improves lipoprotein subclass profile and liver fat in type 2 diabetes independent of body weight: evidence from two randomized controlled trials
Thomsen MN, Skytte MJ, Samkani A, et al.
Am J Clin Nutr. 2024:S0002-9165(24)01425-4.
Leggi
The role of the glucagon-FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition
Moreno-Lopez M, Louvet I, Delalleau N, et al.
Diabetes Obes Metab. Pub. online 1 Dec 2024.
Leggi
A randomized trial comparing inhaled insulin plus basal insulin versus usual care in adults with type 1 diabetes
Hirsch IB, Beck RW, Marak MC, et al.
Diabetes Care. 2024:dc241832.
Leggi
Use of SGLT2i versus DPP-4i as an add-on therapy and the risk of PAD-related surgical events (amputation, stent placement, or vascular surgery): a cohort study in veterans with diabetes
Griffin KE, Snyder K, Snyder K, et al.
Diabetes Care. 2024:dc241546.
Leggi